Dynacure

Dynacure

Dynacure

Dynacure develops new treatments for serious orphan disorders, such as Centronuclear Myopathies.
Raised
$55M
Follow us
Alexa global traffic share
Latest funding
$55,000,000
Venture capital (Series C) - 2020
Bpifrance Perceptive Advisors Tekla Capital Management +3
Team Size
1–10
Employees
Location
Headquarters
$55,000,000 Venture capital (Series C)
Xconomy

Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic